News in the Life Sciences Industry

DUBLIN, July 30, 2020 /PRNewswire/ --

LAS VEGAS, July 30, 2020 /PRNewswire/ -- CrossRoads of Southern Nevada, NV's top drug and alcohol addiction treatment... Read more ››

WASHINGTON, July 30, 2020 /PRNewswire/ -- At today's White House Roundtable, plasma industry leader and CSL CEO Paul Perreault urged people who have recovered from COVID-19 to consider donating plasma toward the development of a potential hyperimmune globulin to treat people with serious... Read more ››

SILVER SPRING, Md., July 30, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced a new protocol for the development and registration of antimicrobial treatments for preharvest agricultural water, such as the water used in farm irrigation systems. The protocol was developed... Read more ››

CLEVELAND, July 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2020.

SAN DIEGO, July 30, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the William Blair Biotech Focus Conference 2020 at 12:00 p.m. ET on Thursday, August 6, 2020. Kyle Gano, Chief Business Development and Strategy Officer, will participate in a panel session... Read more ››

MADISON, Wis., July 30, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $268.9 million for the second quarter ended June 30, 2020, compared to $199.9 million for the same period of 2019.

ATLANTA, July 30, 2020 /PRNewswire/ --

INCLINE VILLAGE, Nev., July 30, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it... Read more ››

PHILADELPHIA, July 30, 2020 /PRNewswire/ -- In the early days of the COVID-19 pandemic, the SARS-CoV-2 virus seemed only rarely to have serious complications in children. However, by April 2020, pediatricians had begun recognizing a syndrome in children who tested positive for COVID-19 involving... Read more ››

NEW YORK, July 30, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that it will report financial results... Read more ››